Medical Design Technology -
20 Jul 2018 15:00
News Two companies have agreed to join forces to create a new company called "Consortium.AI" , which will apply the latest advances in AI to discovery of novel small molecules for the Duchenne Muscular Dystrophy and other rare orphan diseases... Contributed Author: Insilico Medicine Topics: STEM
Share this Article